We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
+13.82%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$2.46B
AUM Growth
-$102M
Cap. Flow
-$311M
Cap. Flow %
-12.63%
Top 10 Hldgs %
59.49%
Holding
158
New
14
Increased
44
Reduced
53
Closed
16

Top Buys

Rank Stock Value
1
BALL icon
Ball Corp
BALL
+$28.6M
2
TRU icon
TransUnion
TRU
+$12.1M
3
V icon
Visa
V
+$6.83M
4
BAX icon
Baxter International
BAX
+$6.01M
5
MNST icon
Monster Beverage
MNST
+$3.71M

Top Sells

Rank Stock Value
1
MCHP icon
Microchip Technology
MCHP
+$113M
2
CSL icon
Carlisle Companies
CSL
+$83.9M
3
NXPI icon
NXP Semiconductors
NXPI
+$61M
4
PDD icon
Pinduoduo
PDD
+$26.6M
5
RH icon
RH
RH
+$25.2M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 20.74%
2 Energy 15.66%
3 Healthcare 14.23%
4 Financials 14.09%
5 Technology 13.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INBX
51
DELISTED
Inhibrx, Inc. Common Stock
INBX
$6.37M 0.26%
167,763
-61,273
-27% -$1.31M
GOSS icon
52
Gossamer Bio
GOSS
$86.6M
$6.35M 0.26%
6,954,110
+1,596,332
+30% +$1.18M
BIIB icon
53
Biogen
BIIB
$30.6B
$6.22M 0.25%
24,020
-24
-0.1% -$5.89K
ALLE icon
54
Allegion
ALLE
$14.1B
$5.57M 0.23%
43,948
+12,441
+39% +$1.33M
CHWY icon
55
Chewy
CHWY
$9.36B
$4.74M 0.19%
200,448
+133,066
+197% +$2.62M
ZYME icon
56
Zymeworks
ZYME
$1.68B
$4.26M 0.17%
409,839
– –
MNST icon
57
Monster Beverage
MNST
$89.3B
$4M 0.16%
+69,386
New +$3.71M
MRUS
58
DELISTED
Merus
MRUS
$3.91M 0.16%
142,029
– –
RCUS icon
59
Arcus Biosciences
RCUS
$3.65B
$3.9M 0.16%
204,398
– –
NFLX icon
60
Netflix
NFLX
$315B
$3.86M 0.16%
79,380
+7,590
+11% +$331K
AMZN icon
61
Amazon
AMZN
$2.98T
$3.75M 0.15%
24,663
+2,050
+9% +$287K
ABSI icon
62
Absci
ABSI
$1.51B
$3.52M 0.14%
837,596
-469,072
-36% -$870K
AVGO icon
63
Broadcom
AVGO
$2.02T
$3.49M 0.14%
+31,260
New +$2.96M
WVE icon
64
Wave Life Sciences
WVE
$1.19B
$3.31M 0.13%
655,331
+200,000
+44% +$1.07M
IMTX icon
65
Immatics
IMTX
$1.33B
$3.3M 0.13%
313,574
+45,363
+17% +$418K
GPCR icon
66
Structure Therapeutics
GPCR
$3.76B
$3.14M 0.13%
77,093
+24,632
+47% +$1.41M
VERA icon
67
Vera Therapeutics
VERA
$2.27B
$3.08M 0.13%
200,302
– –
CNTA
68
DELISTED
Centessa Pharmaceuticals
CNTA
$3.03M 0.12%
381,083
+43,539
+13% +$292K
ARWR icon
69
Arrowhead Research
ARWR
$12.5B
$2.97M 0.12%
97,168
– –
VEEV icon
70
Veeva Systems
VEEV
$38.1B
$2.88M 0.12%
14,935
+11,423
+325% +$2.15M
CNTG
71
DELISTED
Centogene N.V. Common Shares
CNTG
$2.85M 0.12%
2,376,442
-708
-0% -$827
COGT icon
72
Cogent Biosciences
COGT
$7.03B
$2.8M 0.11%
475,634
-203
-0% -$1.56K
TKNO icon
73
Alpha Teknova
TKNO
$352M
$2.75M 0.11%
736,540
-97,989
-12% -$242K
OMGA
74
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$2.67M 0.11%
886,782
-235
-0% -$476
ORCL icon
75
Oracle
ORCL
$435B
$2.55M 0.1%
24,143
– –
1 2
3
4 5

Similar funds

LCG
Lisanti Capital Growth New York $397M AUM 178.66% 1-Year Est. Return
EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
GPC
Greenstone Partners & Co Larkspur, California $395M AUM 35.56% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Platinum Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, Platinum Investment Management held 158 positions worth $2.46B, down 4% from $2.56B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Platinum Investment Management withdrew a net $311M in Q4 2023, closing 16 positions and reducing 53 holdings. Its most notable exit was Carlisle Companies, an estimated $83.9M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 18% a quarter earlier, followed by Energy and Healthcare.

Against the trend, Platinum Investment Management opened a new position in Visa worth $7.21M.

  • Platinum Investment Management's largest Q4 2023 buy was Visa: 27,693 shares worth $7.21M.
  • Platinum Investment Management added most to Ball Corp in Q4 2023, an estimated $28.6M increase.
  • Platinum Investment Management's biggest Q4 2023 reduction was Microchip Technology, cutting an estimated $113M.
  • Platinum Investment Management fully exited Carlisle Companies in Q4 2023, selling an estimated $83.9M.
  • Platinum Investment Management's ten largest holdings make up 59% of its $2.46B portfolio in Q4 2023.
  • Platinum Investment Management opened 14 new positions and closed 16 in Q4 2023.
  • Platinum Investment Management's portfolio value fell 4% quarter-over-quarter to $2.46B.

Based on Platinum Investment Management's 13F filing for Q4 2023, filed 13 Feb 2024.